Item 4. CONTROLS AND PROCEDURES

CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of management, including

our principal executive officer and

principal financial officer, we evaluated the effectiveness of the design and operation of our disclosure controls and

procedures as of the end of the period covered by this quarterly report

as such term is defined in Rules 13a-15(e)

and 15d-15(e) promulgated under the Securities Exchange Act of 1934, as

amended (the “Exchange Act”).

Based

on this evaluation, our management, including our principal executive officer and principal

financial officer,

concluded that our disclosure controls and procedures were effective as of March

26, 2022, to ensure that all

material information required to be disclosed by us in reports that we file

or submit under the Exchange Act is

accumulated and communicated to them as appropriate to allow timely

decisions regarding required disclosure and

that all such information is recorded, processed, summarized and reported

within the time periods specified in the

SEC’s rules and forms.

Changes in Internal Control over Financial Reporting

The combination of continued acquisition integrations and system

implementation undertaken during the quarter

and carried over from prior quarters when considered in the aggregate, represents

a material change in our internal

control over financial reporting.

During the three months ended March 26, 2022, post-acquisition integration

related activities continued for our

dental and medical businesses acquired during prior quarters.

These acquisitions, the majority of which utilize

separate information and financial accounting systems, have been

included in our consolidated financial statements

since their respective dates of acquisition.

In addition, during the quarter ended March 26, 2022, we completed the

systems implementation activities to

upgrade the warehouse management system for our Australian dental

business.

All continued acquisition integrations and systems implementation involve

necessary and appropriate change-

management controls that are considered in our quarterly assessment of

the design and operating effectiveness of

our internal control over financial reporting.

Limitations of the Effectiveness of Internal Control

A control system, no matter how well conceived and operated, can provide

only reasonable, not absolute, assurance

that the objectives of the internal control system are met.

Because of the inherent limitations of any internal control

system, no evaluation of controls can provide absolute assurance that all control

issues, if any, within a company

have been detected.

PART

II.

OTHER INFORMATION

ITEM 1.

LEGAL PROCEEDINGS

For a discussion of Legal Proceedings, see

Note 9–Legal Proceedings

of the Notes to the Condensed Consolidated

Financial Statements included under Item 1.